Literature DB >> 15823515

The multitude of targets for the immune system and drug therapy in the fungal cell wall.

Leonardo Nimrichter1, Marcio L Rodrigues, Elaine G Rodrigues, Luiz R Travassos.   

Abstract

Recent studies on fungi revealed that several cytosolic and membrane components migrate to the cell wall together with secreted proteins and biosynthetic polysaccharides to build a dynamic immunoreactive structure. New aspects of fungal cell wall assembly and biosynthesis, focusing on the potential of glycolipids, melanin, heat-shock proteins, histone and surface antigens as targets of drugs and antifungal antibodies are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823515     DOI: 10.1016/j.micinf.2005.03.002

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  34 in total

1.  Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.

Authors:  Marcio L Rodrigues; Leonardo Nimrichter; Débora L Oliveira; Susana Frases; Kildare Miranda; Oscar Zaragoza; Mauricio Alvarez; Antonio Nakouzi; Marta Feldmesser; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2006-11-17

2.  Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides.

Authors:  Leonardo Nimrichter; Mariana D Cerqueira; Eduardo A Leitão; Kildare Miranda; Ernesto S Nakayasu; Sandro R Almeida; Igor C Almeida; Celuta S Alviano; Eliana Barreto-Bergter; Marcio L Rodrigues
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2007-08-20       Impact factor: 3.441

4.  Functional characterization of the Aspergillus nidulans glucosylceramide pathway reveals that LCB Δ8-desaturation and C9-methylation are relevant to filamentous growth, lipid raft localization and Psd1 defensin activity.

Authors:  C M Fernandes; P A de Castro; A Singh; F L Fonseca; M D Pereira; T V M Vila; G C Atella; S Rozental; M Savoldi; M Del Poeta; G H Goldman; E Kurtenbach
Journal:  Mol Microbiol       Date:  2016-08-25       Impact factor: 3.501

Review 5.  Atomic Force Microscopy: A Promising Tool for Deciphering the Pathogenic Mechanisms of Fungi in Cystic Fibrosis.

Authors:  Stéphane Cuenot; Jean-Philippe Bouchara
Journal:  Mycopathologia       Date:  2017-11-11       Impact factor: 2.574

6.  Vesicular Trans-Cell Wall Transport in Fungi: A Mechanism for the Delivery of Virulence-Associated Macromolecules?

Authors:  Marcio L Rodrigues; Leonardo Nimrichter; Debora L Oliveira; Joshua D Nosanchuk; Arturo Casadevall
Journal:  Lipid Insights       Date:  2008-08

7.  Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection.

Authors:  Marcio L Rodrigues; Li Shi; Eliana Barreto-Bergter; Leonardo Nimrichter; Sandra E Farias; Elaine G Rodrigues; Luiz R Travassos; Joshua D Nosanchuk
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

Review 8.  The impact of proteomics on the understanding of functions and biogenesis of fungal extracellular vesicles.

Authors:  Marcio L Rodrigues; Ernesto S Nakayasu; Igor C Almeida; Leonardo Nimrichter
Journal:  J Proteomics       Date:  2013-04-10       Impact factor: 4.044

9.  Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence.

Authors:  Marcio L Rodrigues; Ernesto S Nakayasu; Debora L Oliveira; Leonardo Nimrichter; Joshua D Nosanchuk; Igor C Almeida; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2007-11-26

10.  Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan.

Authors:  Marcio L Rodrigues; Mauricio Alvarez; Fernanda L Fonseca; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2007-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.